These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3054227)

  • 1. Systemic and glomerular hypertension in progressive renal disease.
    Anderson S
    Kidney Int Suppl; 1988 Sep; 25():S119-21. PubMed ID: 3054227
    [No Abstract]   [Full Text] [Related]  

  • 2. Progression of chronic renal disease: role of systemic and glomerular hypertension.
    Anderson S
    Am J Kidney Dis; 1989 Jun; 13(6 Suppl 1):8-12. PubMed ID: 2735325
    [No Abstract]   [Full Text] [Related]  

  • 3. Intraglomerular hypertension: implications and drug treatment.
    Anderson S; Brenner BM
    Annu Rev Med; 1988; 39():243-53. PubMed ID: 3285775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive treatment and glomerular size selectivity in hypertensive patients with renal parenchymal disease and proteinuria.
    Shand BI; Lewis JG; Elder PA; Agarwal M
    Clin Nephrol; 2002 Oct; 58(4):321-4. PubMed ID: 12400851
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of systemic and glomerular hypertension in progressive glomerular injury.
    Herrera-Acosta J
    Kidney Int Suppl; 1994 Feb; 45():S6-10. PubMed ID: 8158901
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of hypertension.
    Fogo A; Kon V
    Semin Nephrol; 1996 Nov; 16(6):555-66. PubMed ID: 9125800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of antihypertensive therapy on progression of experimental renal disease.
    Dworkin LD
    J Hum Hypertens; 1996 Oct; 10(10):663-8. PubMed ID: 9004091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can calcium channel blockers preserve renal function better than diuretics during antihypertensive treatment?
    Fukuda M; Kimura G
    Arch Intern Med; 2005 Jun; 165(11):1312; author reply 1312-3. PubMed ID: 15956015
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hypertension during the course of kidney diseases].
    Wiecek A
    Przegl Lek; 1997; 54(11):773-6. PubMed ID: 9501687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing hypertensive kidney disease: the critical role of combination therapy.
    Bakris GL
    Am J Hypertens; 2005 Apr; 18(4 Pt 2):93S-94S. PubMed ID: 15837550
    [No Abstract]   [Full Text] [Related]  

  • 12. [Renal involvement in scleroderma].
    Boffa JJ; Rossert J
    Rev Prat; 2002 Nov; 52(17):1910-4. PubMed ID: 12532868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glomerular-capillary hypertension. Experimental findings and their clinical importance].
    Anderson S; Brenner BM
    Dtsch Med Wochenschr; 1988 Oct; 113(40):1543-5. PubMed ID: 3048961
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of hypertension in renal disease.
    Baldwin DS; Neugarten J
    Am J Kidney Dis; 1985 Apr; 5(4):A57-70. PubMed ID: 3887904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertension and renal disease].
    Kamper AL; Pedersen EB; Strandgaard S
    Ugeskr Laeger; 2009 Jun; 171(25):2109-13. PubMed ID: 19671393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vascular impact of anti-hypertensive treatment and renal protection].
    Mogensen CE
    Curr Med Res Opin; 2005; 21 Suppl 5():S23-8. PubMed ID: 16197649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of antihypertensive treatment on target organs].
    Fregoso Padilla J
    Arch Cardiol Mex; 2002; 72 Suppl 1():S58-63. PubMed ID: 12001872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood coagulation and renal disease.
    McKay DG
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):771-807. PubMed ID: 4154432
    [No Abstract]   [Full Text] [Related]  

  • 19. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.
    Watanabe D; Tanabe A; Naruse M; Morikawa S; Ezaki T; Takano K
    Hypertens Res; 2009 Sep; 32(9):807-15. PubMed ID: 19662019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antihypertensive therapy in renal failure].
    Mayer G
    Acta Med Austriaca; 1995; 22(3):51-3. PubMed ID: 8571752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.